|
1
|
Bonasio R, Tu S and Reinberg D: Molecular
signals of epigenetic states. Science. 330:612–616. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herceg Z and Paliwal A: Epigenetic
mechanisms in hepatocellular carcinoma: How environmental factors
influence the epigenome. Mutat Res. 727:55–61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Holliday R and Grigg GW: DNA methylation
and mutation. Mutat Res. 285:61–67. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamanaka M, Watanabe M, Yamada Y, Takagi
A, Murata T, Takahashi H, Suzuki H, Ito H, Tsukino H, Katoh T, et
al: Altered methylation of multiple genes in carcinogenesis of the
prostate. Int J Cancer. 106:382–387. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hoque MO, Begum S, Topaloglu O, Jeronimo
C, Mambo E, Westra WH, Califano JA and Sidransky D: Quantitative
detection of promoter hypermethylation of multiple genes in the
tumor, urine and serum DNA of patients with renal cancer. Cancer
Res. 64:5511–5517. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guan CN, Chen XM, Lou HQ, Liao XH, Chen BY
and Zhang PW: Clinical significance of axin and β-catenin protein
expression in primary hepatocellular carcinomas. Asina Pac J Cancer
Prev. 13:677–681. 2012. View Article : Google Scholar
|
|
7
|
Zhang YJ, Chen Y, Ahsan H, Lunn RM, Chen
SY, Lee PH, Chen CJ and Santella RM: Silencing of glutathione
S-transferase P1 by promoter hypermethylation and its relationship
to environmental chemical carcinogens in hepatocellular carcinoma.
Cancer Lett. 221:135–143. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tchou JC, Lin X, Freije D, Isaacs WB,
Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S and Nelson
WG: GSTP1 CpG island DNA hypermethylation in hepatocellular
carcinomas. Int J Oncol. 16:663–676. 2000.PubMed/NCBI
|
|
9
|
Jin M, Piao Z, Kim NG, Park C, Shin EC,
Park JH, Jung HJ, Kim CG and Kim H: p16 is a major inactivation
target in hepatocellular carcinoma. Cancer. 89:60–68. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhong S, Yeo W, Tang MW, Wong N, Lai PB
and Johnson PJ: Intensive hypermethylation of the CpG island of Ras
association domain family 1A in hepatitis B virus-associated
hepatocellular carcinomas. Clin Cancer Res. 9:3376–3382.
2003.PubMed/NCBI
|
|
11
|
Yamane B and Weber S: Liver-directed
treatment modalities for primary and secondary hepatic tumors. Surg
Clin North Am. 89:97–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Delis SG, Bakoyiannis A, Tassopoulos N,
Athanassiou K, Kelekis D, Madariaga J and Dervenis C: Hepatic
resection for hepatocellular carcinoma exceeding Milan criteria.
Surg Oncol. 19:200–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakazato H, Suzuki K, Matsui H, et al:
Association of genetic polymorphisms of glutathione-S-transferase
genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk
in a Japanese population. Anticancer Res. 23:2897–2902.
2003.PubMed/NCBI
|
|
14
|
Narimatsu T, Tamori A, Koh N, Kubo S,
Hirohashi K, Yano Y, Arakawa T, Otani S and Nishiguchi S: p16
promoter hypermethylation in human hepatocellular carcinoma with or
without hepatitis virus infection. Intervirology. 47:26–31. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chadwick RB, Jiang GL, Bennington GA, Yuan
B, Johnson CK, Stevens MW, Niemann TH, Peltomaki P, Huang S and de
la Chapelle A: Candidate tumor suppressor RIZ is frequently
involved in colorectal carcinogenesis. Proc Natl Acad Sci USA.
97:2662–2667. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen LB, Xu JY, Yang Z and Wang GB:
Silencing SMYD3 in hepatoma demethylates RIZ1 promoter induces
apoptosis and inhibits cell proliferation and migration. World J
Gastroenterol. 13:5718–5724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang HW, Chan A, Kwong DL, Wei WI, Sham
JS and Yuen AP: Detection of hypermethylated RIZ1 gene in primary
tumor, mouth and throat rinsing fluid, nasopharyngeal swab and
peripheral blood of nasopharyngeal carcinoma patient. Clin Cancer
Res. 9:1033–1038. 2003.PubMed/NCBI
|
|
18
|
Nomoto S, Kinoshita T, Kato K, Otani S,
Kasuya H, Takeda S, Kanazumi N, Sugimoto H and Nakao A:
Hypermethylation of multiple genes as clonal markers in
multicentric hepatocellular carcinoma. Br J Cancer. 97:1260–1265.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Damman R, Li C, Yoon JH, Chin PL, Bates S
and Pfeifer GP: Epigenetic inactivation of RAS association domain
family protein from the lung tumor suppressor locus 3p21.3. Nat
Genet. 25:315–319. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J,
Chen J, Zhang L, Wu M, Zhen S and Zhu J: Methylation profiling of
twenty promoter-CpG islands of genes which may contribute to
hepatocellular carcinogenesis. BMC Cancer. 2:292002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ and
Kang GH: Aberrant CpG island hypermethylation along multistep
hepatocarcinogenesis. Am J Pathol. 163:1371–1378. 2003. View Article : Google Scholar : PubMed/NCBI
|
